	Reply to: Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer. J Clin Oncol Valle LF, Calais J, Kishan AU. PMID: 41849721 [PubMed - as supplied by publisher]
	Comments on the LUNAR Trial in Oligorecurrent Hormone-Sensitive Prostate Cancer. J Clin Oncol Bölek H, Ürün Y. PMID: 41849717 [PubMed - as supplied by publisher]
	Applying multimodal dendrimers for prostate cancer theranostics. Nanomedicine (Lond) Lesniak WG, Pomper MG. PMID: 41849182 [PubMed - as supplied by publisher]
	Urine culture-guided antibiotic prophylaxis reduces febrile pyelonephritis after ureteral stent removal following radical cystectomy. World J Urol Kitano H, Watanabe E, Tadera K, Nakano Y, Tasaka S, Yukihiro K, Okazaki M, Nomura N, Hatayama T, Shikuma H, Iwane K, Tasaka R, Kohada Y, Takemoto K, Miyamoto S, Naito M, Kobatake K, Sekino Y, Goto K, Goriki A, Hieda K, Hayashi T, Kashiyama S, Ohge H, Hinata N. PMID: 41848879 [PubMed - indexed for MEDLINE]
	Use of MRI in the diagnosis of bladder cancer: a health economic analysis. BJU Int Sathianathen N, Perera M, Ischia J, Lawrentschuk N, Bolton D. PMID: 41848524 [PubMed - as supplied by publisher]
	Role of urinary leukocytes in the risk stratification of prostate cancer using nonlinear stacking learning strategy: a bi-cohort diagnostic study. Front Oncol Xia S, Ran Z, Cheng M, Zhu H, Yang C, Wu X. PMID: 41847692 [PubMed]
	Correlation of mRENAL score with clinical outcomes after CT-guided renal cell carcinoma cryoablation: A retrospective observational study. Qatar Med J Elhissi M, Musa E, Alahmad YM, Alaani A, Omar A, Elmajdoub A, Al-Rumaihi K, Alturkistani H, Alahmad MAM, Barah A. PMID: 41847204 [PubMed]
	Prognostic and predictive factors of immune checkpoint inhibitor therapy in urinary bladder cancer. Pathol Oncol Res Váradi M, Magyar B, Széles Á, Korda S, Németh B, Simon B, Reis H, Oláh C, Horváth O, Dér B, Nyirády P, Szarvas T. PMID: 41846864 [PubMed - indexed for MEDLINE]
	From cold to hot: A 'Prime, Activate, Sustain' framework for precision remodeling of the tumor microenvironment in prostate cancer. Crit Rev Oncol Hematol Li H, Liao K, Zhang M. PMID: 41845983 [PubMed - as supplied by publisher]
	A retrospective study comparing multimodal fusion biopsy and conventional cognitive fusion biopsy for diagnosing prostate cancer. BMC Urol Wu C, Jiao Z, Wu H, Liu X, Jiang X, Wang C, Shi Y, Lv Z. PMID: 41845344 [PubMed - as supplied by publisher]
	Is MRI/US-guided fusion biopsy ready to replace systematic biopsy in detecting clinically significant prostate carcinoma? - a retrospective study. BMC Urol Ökrösi A, Svarer AP, Rosta G, Wambacher B, Heinz G. PMID: 41845327 [PubMed - as supplied by publisher]
	Cardiometabolic risk and metabolic syndrome with prostate cancer-an inverse probability weighted study. BMC Public Health Wang J, Zheng X, Jiang S, Ding M, Wang D, An H, Tao N. PMID: 41845281 [PubMed - as supplied by publisher]
	Artificial-intelligence models vs. radiologists in the detection of clinically significant prostate cancer on mpMRI: a meta-analysis. Eur Radiol Andrade MA, Rodrigues H, Colhado CH, Godinho NJS, Dos Santos RD, de Andrade AL, Goodstein T. PMID: 41844851 [PubMed - as supplied by publisher]
	[Cryoablation for Renal Cell Carcinoma: Update on an Established Ablative Technique]. Aktuelle Urol Auer TA, Lüdemann WM, Ralla B, Gebauer B, Collettini F. PMID: 41844219 [PubMed - as supplied by publisher]
	Radiotherapy Utilization Patterns Among Patients With Metastatic Renal Cell Carcinoma of the Spine: A National Claims Database Study. Am J Clin Oncol Ndika TC, Luo EJ, Woo J, Ahmed R, Rivera N, Ray EJ, Crowell KA, Johnson E, Mullikin TC, Erickson M, Goodwin CR. PMID: 41844167 [PubMed - as supplied by publisher]
	Multidisciplinary Care of Patients With Penile Cancer. Am Soc Clin Oncol Educ Book Medina LG, Hatoum F, Paesano N, Zemp L, Grass D, Morse B, Dhillon J, Chahoud J, Pettaway C, Spiess PE. PMID: 41843888 [PubMed - indexed for MEDLINE]
	Bladder Preservation Strategies in Muscle-Invasive Bladder Cancer. Am Soc Clin Oncol Educ Book Li J, Ballas L, Ghatalia P. PMID: 41843887 [PubMed - indexed for MEDLINE]
	Primary Mucinous Bladder Adenocarcinoma. Prague Med Rep Turan S, Gezmi, , Ayd, Balc. PMID: 41843547 [PubMed - indexed for MEDLINE]
	Prospective comparative evaluation of clinical efficacy and safety of Intravesical gemcitabine-docetaxel versus BCG in adjuvant management of BCG-naive non-muscle invasive urothelial bladder cancer in Indian population. Int Urol Nephrol Srivastava A, Trivedi S, Singh Y, Kumar U, Kumar L, Data S, Kumar A, Sankhwar SN. PMID: 41843343 [PubMed - as supplied by publisher]
	Enhanced nodal staging by molecular detection of KLK3, FOLH1, and PCA3 in prostate cancer. Discov Oncol Wang SQ, Wang H, Xie DW, Chu YF, Yang PS, He WF, Wang W, Wang JW. PMID: 41843002 [PubMed - as supplied by publisher]

Articles 1 - 20 / 176898

Page 1 of 8845



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy